Search research articles
Contact Us
Filters
Showing results (191-200 of 224) with videos related to
Page
of 23
Sort By:
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
June 3, 2008
Characterization of patients with acute chest pain using cardiac magnetic resonance imaging
Vinzenz Hombach, Nico Merkle, Hans A Kestler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 13, 2023
Albumin-Binding and Conventional PSMA Ligands in Combination with <sup>161</sup>Tb: Biodistribution, Dosimetry, and Preclinical Therapy
Viviane J Tschan, Sarah D Busslinger, Peter Bernhardt, et al.
Annals of Transplantation
|
January 16, 2015
Sustained virological response to antiviral therapy in a randomized trial of cyclosporine versus tacrolimus in liver transplant patients with recurrent hepatitis C infection
Christophe Duvoux, Federico Villamil, Eberhard L Renner, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 29, 2019
Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer
Cristina Müller, Christoph A Umbricht, Nadezda Gracheva, et al.
Expert Opinion on Drug Safety
|
July 8, 2020
Wound healing adverse events in kidney transplant recipients receiving everolimus with reduced calcineurin inhibitor exposure or current standard-of-care: insights from the 24-month TRANSFORM study
Franco Citterio, Mitchell Henry, Dean Y Kim, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 14, 2022
EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands
Katarina Sjögreen Gleisner, Nicolas Chouin, Pablo Minguez Gabina, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 6, 2006
Administered activity and metastatic cure probability during radioimmunotherapy of ovarian cancer in nude mice with 211At-MX35 F(ab')2
Jörgen Elgqvist, Håkan Andersson, Peter Bernhardt, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 24, 2024
Comparison of the tolerability of <sup>161</sup>Tb- and <sup>177</sup>Lu-labeled somatostatin analogues in the preclinical setting
Sarah D Busslinger, Ana Katrina Mapanao, Kristel Kegler, et al.
Lancet (London, England)
|
April 18, 2003
Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: a prospective, randomised study
Heyder Omran, Harald Schmidt, Matthias Hackenbroch, et al.
BMJ Open
|
October 8, 2021
Application of the iBox prognostication system as a surrogate endpoint in the TRANSFORM randomised controlled trial: proof-of-concept study
Olivier Aubert, Gillian Divard, Julio Pascual, et al.
Page
of 23
Search research articles
Search
Showing results (191-200 of 224) with videos related to
Sort By:
Page
of 23
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
June 3, 2008
Characterization of patients with acute chest pain using cardiac magnetic resonance imaging
Vinzenz Hombach, Nico Merkle, Hans A Kestler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 13, 2023
Albumin-Binding and Conventional PSMA Ligands in Combination with <sup>161</sup>Tb: Biodistribution, Dosimetry, and Preclinical Therapy
Viviane J Tschan, Sarah D Busslinger, Peter Bernhardt, et al.
Annals of Transplantation
|
January 16, 2015
Sustained virological response to antiviral therapy in a randomized trial of cyclosporine versus tacrolimus in liver transplant patients with recurrent hepatitis C infection
Christophe Duvoux, Federico Villamil, Eberhard L Renner, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 29, 2019
Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer
Cristina Müller, Christoph A Umbricht, Nadezda Gracheva, et al.
Expert Opinion on Drug Safety
|
July 8, 2020
Wound healing adverse events in kidney transplant recipients receiving everolimus with reduced calcineurin inhibitor exposure or current standard-of-care: insights from the 24-month TRANSFORM study
Franco Citterio, Mitchell Henry, Dean Y Kim, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 14, 2022
EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands
Katarina Sjögreen Gleisner, Nicolas Chouin, Pablo Minguez Gabina, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 6, 2006
Administered activity and metastatic cure probability during radioimmunotherapy of ovarian cancer in nude mice with 211At-MX35 F(ab')2
Jörgen Elgqvist, Håkan Andersson, Peter Bernhardt, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 24, 2024
Comparison of the tolerability of <sup>161</sup>Tb- and <sup>177</sup>Lu-labeled somatostatin analogues in the preclinical setting
Sarah D Busslinger, Ana Katrina Mapanao, Kristel Kegler, et al.
Lancet (London, England)
|
April 18, 2003
Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: a prospective, randomised study
Heyder Omran, Harald Schmidt, Matthias Hackenbroch, et al.
BMJ Open
|
October 8, 2021
Application of the iBox prognostication system as a surrogate endpoint in the TRANSFORM randomised controlled trial: proof-of-concept study
Olivier Aubert, Gillian Divard, Julio Pascual, et al.
Page
of 23